Cite
HARVARD Citation
Rutter, K. et al. (2016). Von Willebrand factor antigen (vWF-Ag): A non-invasive predictor of treatment response and serious adverse events in HCV patients with interferon triple therapy. Digestive and liver disease. 48 (10), pp. 1194-1199. [Online].